Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-29

Clinical Trial Update: Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression [NA]

View source ↗

Summary

A completed clinical trial evaluating subanesthetic ketamine plus electroconvulsive treatment for treatment resistant depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Treatment Resistant Depression, Major Depressive Disorder | NA | Status: COMPLETED | Results posted: 2019-08-29